Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, wasting billions of dollars each year and jeopardizing critical scientific ...

Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinical settings ...

The project team led by Professor Zheng Zongli (right) of CityUHK’s Department of Biomedical Sciences, will focus on liver and cardiovascular genetic diseases, harnessing state-of-the-art “DNA surgery ...